151 related articles for article (PubMed ID: 17217945)
21. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
[TBL] [Abstract][Full Text] [Related]
22. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
23. The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake.
Valenti M; Cottone E; Martinez R; De Pedro N; Rubio M; Viveros MP; Franzoni MF; Delgado MJ; Di Marzo V
J Neurochem; 2005 Nov; 95(3):662-72. PubMed ID: 16135090
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein.
Pelorosso FG; Gago JE; Del Rey G; Menéndez SD; Errasti AE; Rothlin RP
Eur J Pharmacol; 2009 Jan; 602(1):176-9. PubMed ID: 19022239
[TBL] [Abstract][Full Text] [Related]
25. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
26. Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects.
Wiley JL; Dewey MA; Jefferson RG; Winckler RL; Bridgen DT; Willoughby KA; Martin BR
Life Sci; 2000 Aug; 67(13):1573-83. PubMed ID: 10983852
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
28. Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani S; Cuomo V; Piomelli D
Trends Mol Med; 2003 Nov; 9(11):474-8. PubMed ID: 14604824
[TBL] [Abstract][Full Text] [Related]
29. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex.
Yuece B; Sibaev A; Broedl UC; Marsicano G; Göke B; Lutz B; Allescher HD; Storr M
Neurogastroenterol Motil; 2007 Sep; 19(9):744-53. PubMed ID: 17727394
[TBL] [Abstract][Full Text] [Related]
32. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
Wenger T; Ledent C; Tramu G
Neuroendocrinology; 2003 Dec; 78(6):294-300. PubMed ID: 14688442
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
Chang L; Luo L; Palmer JA; Sutton S; Wilson SJ; Barbier AJ; Breitenbucher JG; Chaplan SR; Webb M
Br J Pharmacol; 2006 May; 148(1):102-13. PubMed ID: 16501580
[TBL] [Abstract][Full Text] [Related]
35. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide.
Osei-Hyiaman D; Depetrillo M; Harvey-White J; Bannon AW; Cravatt BF; Kuhar MJ; Mackie K; Palkovits M; Kunos G
Neuroendocrinology; 2005; 81(4):273-82. PubMed ID: 16131814
[TBL] [Abstract][Full Text] [Related]
36. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
37. Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors.
Ghasemi M; Sadeghipour H; Dehpour AR
BJU Int; 2007 Dec; 100(6):1385-90. PubMed ID: 17850365
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
[TBL] [Abstract][Full Text] [Related]
39. IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei.
Currie S; Rainbow RD; Ewart MA; Kitson S; Pliego EH; Kane KA; McCarron JG
J Mol Cell Cardiol; 2008 Dec; 45(6):804-11. PubMed ID: 18692061
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
Glaser ST; Gatley SJ; Gifford AN
J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]